Articles

CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki, and Helsinki University Hospital Comprehensive Cancer Center, Finland
Department of Hematology, St Olavs Hospital, Trondheim, Norway
Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden
Vol. 103 No. 3 (2018): March, 2018 https://doi.org/10.3324/haematol.2017.169946